Pharmaceutical

Prokarium bolsters IP portfolio with two new US patents

UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.

Nov 5, 2024 - 06:00
Prokarium bolsters IP portfolio with two new US patents
UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.
Read the original article

Tags:

Previous Article

US Election: In close race, tiny Senate majority, not President, will hold power

Next Article

FDA grants fast track status to FELIQS’s FLQ-101 to prevent ROP

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare advisers endorse reforms to lower drug spending

STAT+: Medicare advisers endorse reforms to lower drug ...

Apr 13, 2023

Almirall sees highest patent filings and grants during ...

Dec 10, 2023

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

After ‘SNL’ skit on sickle cell CRISPR therapy, advocat...

Dec 21, 2023